Germans Trias i Pujol Research Institute (IGTP)’s Post

🆕 We are proud to announce that Germans Trias i Pujol Research Institute (IGTP) has once again been reaccredited as a Instituto de Investigación Sanitaria (IIS) by Instituto de Salud Carlos III (ISCIII). This prestigious recognition not only reinforces our position as a national leader in biomedical research management but also secures our status as an IIS for the next five years. Dr Julia Garcia Prado, scientific director of IGTP, highlights: "This recognition evaluates excellence in biomedical research and scientific management, ensuring access to public and private resources. This optimal management supports the development of scientific programs and the retention, recruitment, and consolidation of talent in clinical and translational research." Dr Jordi Barretina, director of IGTP, adds: "this reaccreditation allows us to access competitive calls that are only open to accredited institutes, thus increasing our competitiveness. This will allow us to continue accessing resources to develop our research and continue developing innovative projects. Additionally, it opens the door to new international collaborations and increases our visibility". Being accredited as a centre of excellence by ISCIII involves coordinating the management of research and scientific strategy in close collaboration with the other centres that comprise it: the core being the Hospital Universitari Germans Trias i Pujol and the Universitat Autònoma de Barcelona, along with other centres on the Can Ruti campus and and its surronding area (IrsiCaixa, Institut Català d'Oncologia (ICO),Banc de Sang i Teixits, Josep Carreras Leukaemia Research Institute, Institut Guttmann, IDIAPJGol (Institut d'Investigació en Atenció Primària de Salut Jordi Gol), and Consorci Sanitari del Maresme). Our collaborative efforts strengthen our mission to advance biomedical research and improve citizens' health. Learn more: https://lnkd.in/dv42u-W4 #Reaccreditation #IIS #BiomedicalResearch #Innovation #HealthcareExcellence

A project led by Ikerbasque research professor and AXA chair Maurizio Prato has been selected in the CaixaImpulse 2023 call for proposals by a panel of international experts and professionals in the field of life sciences and health from among over 300 pioneering projects submitted to the call. The project, one of 29 innovative #biomedical #research projects with the potential to reach the market and the general public, will receive 50,000 euros from the program to boost its research, and also to provide support through individualized mentoring and training. Fundación ”la Caixa” is thus seeking to assist innovative biomedical projects in validating their assets and specifying their exploitation and valorization strategy, in order to bring them closer to the market. https://lnkd.in/dNVR4grk BRTA - Basque Research & Technology Alliance #cicbiomagunenews

Here are a few things happening at the Brown Biomedical Innovations to Impact accelerator fund to advance the commercialization of faculty projects with the aim to improve research and patient care. #Biotech #lifeSciences #RhodeIsland

🚀 Discover the Future of Healthcare: Chalmers #PrecisionHealthTech Hub 🚀 Exciting news ahead! Chalmers University of Technology is proud to unveil our next step with the groundbreaking Precision HealthTech Hub, poised to revolutionize healthcare as we know it. In partnership with industry leaders like AstraZeneca and GoCo Health Innovation City, alongside esteemed collaborators in the Västra Götalandsregionen, we're forging ahead to create an innovative hub for collaboration and discovery in Europe. But what exactly is precision medicine, and why is it causing such a stir? Put simply, precision medicine is a paradigm shift in healthcare, where treatments are tailored to the individual characteristics of each patient. By harnessing cutting-edge technologies like genetic sequencing and advanced diagnostics, precision medicine offers the promise of more effective, personalized treatments with fewer side effects. So why the surge in investment? Well, the answer lies in the potential of precision medicine to transform patient care and drive better outcomes. With the ability to target specific disease states and molecular markers, precision medicine not only offers hope for patients but also presents a compelling opportunity for investors seeking clear success criteria and tangible results. In 2024, the stars are aligning for precision medicine to take center stage. As we witness advancements in genetic editing, targeted therapies, and biomarker research, the stage is set for a breakthrough year in healthcare innovation. Join us as we embark on this transformative journey towards a future where healthcare is truly personalized, precise, and impactful. Together, let's shape the future of medicine and make a difference in the lives of millions. 💫 Fredrik Höök FoRmulaEx Kristina Lagerstedt Mats Lundqvist Helena Lundberg Nilsson Matti Ahlqvist, Marie Uddenmyr https://lnkd.in/d6JQjWtY

🔬 Explore the next level collaboration between Research Infrastructures and Technology Infrastructures in biomedicine. Within the framework of the RITIFI project, we have conducted several case studies to observe the best practices and challenges and offer recommendations to better the collaboration for innovation in the biomedical field. The RITIFI project aims to enhance the integration and structure of the European R&I landscape by developing a functional framework, providing guidelines for improved visibility and access, establishing a TI-friendly governance model, conducting comprehensive policy analysis, prioritizing investment plans, and fostering inclusive engagement, ultimately accelerating the digital and green transition in Europe. Read our newly published case study and feel free to share with your network! 👇 #biomedicine #innovation #researchinfrastructures #technologyinfrastructures #ritifi

📽️ Dive into the world of medical device innovation with our latest video unveiling the HEU-EFS project! 🚀

Here we are! where #partnership and #innovation for #research enable #healthcare potential #teamwork #research #molecularimaging #ricerca #precisionmedicine Fondazione Policlinico Universitario Agostino Gemelli IRCCS Ergéa #medicinanuleare #nuclearmedicine #petct #radiopharmaceuticals

Innovative Technologies for Bone Regeneration Biomatlante - Advanced Medical Solutions, is happy to announce that we reached a milestone in our innovative pipeline program for Bioceramics, with assigning a dedicated PhD project, conducted by Justine Perarnaud, to focus on driving all the R&D assignments required to support new releases in the next 2-3 years. This project is in collaboration with Regenerative Medicine and Skeleton, Inserm u1229 RMeS laboratory, the REGOS Team, Inserm Grand Ouest, Nantes Université, Oniris Nantes, ANRT - Association Nationale de la Recherche et de la Technologie and supported by #PIA4 funding, and we are very grateful with the level of support and trust of #France2030 #FranceRelance Région Pays de la Loire, and Bpifrance. Advanced Medical Solutions Group is investing on research for more innovative biomimetic Bioceramics to facilitate enhanced tissue engineering and bone tissue regeneration. Watch the space. #RegenerativeMedicine #TissueEngineering #Bioceramics #BoneRegeneration #Medicalinnovation #healthtech